SCHEMBL23367404

SCHEMBL23367404

CCOC(=O)/C(C=O)=N/Nc1ccc(Cl)c(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.51
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
ALDH1A1 P00352 5/20 0.45
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
TSHR P16473 1/20 0.45
NPC1 O15118 3/20 0.45
LMNA P02545 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
MAPT P10636 2/20 0.45
RAB9A P51151 2/20 0.45
ABCB1 P08183 1/20 0.44
KYAT1 Q16773 4/20 0.44
CYP3A4 P08684 1/20 0.43
GAA P10253 2/20 0.41
ATM Q13315 1/20 0.41
HTT P42858 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29873511 1.00 POLB (0.51) POLBKMT2AMEN1ALDH1A1HPGD
SCHEMBL23367356 0.89 MEN1 (0.42) POLBKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL23367271 0.89 TSHR (0.47) KMT2AMEN1ALDH1A1SMN1; SMN2TSHR
SCHEMBL23367423 0.88 POLB (0.49) POLBKMT2AMEN1ALDH1A1HPGD
SCHEMBL29873898 0.88 POLB (0.49) POLBKMT2AMEN1ALDH1A1HPGD
SCHEMBL23367546 0.85 MEN1 (0.60) KMT2AMEN1ALDH1A1HPGDSMN1; SMN2
SCHEMBL23354802 0.85 MEN1 (0.60) KMT2AMEN1ALDH1A1HPGDSMN1; SMN2
SCHEMBL23354800 0.85 MEN1 (0.60) KMT2AMEN1ALDH1A1HPGDSMN1; SMN2
SCHEMBL11765704 0.84 POLB (0.55) POLBKMT2AMEN1ALDH1A1HPGD
SCHEMBL13901605 0.84 POLB (0.55) POLBKMT2AMEN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230027985-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2023-01-26 US disclosed
WO-2021094434-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2021-05-20 WO disclosed
EP-3822265-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS Bayer AG (DE) 2021-05-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027985-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS ADAMTS7, MMP7, ADAMTS1 POLB 2132/4885KMT2A 3100/4885MEN1 2636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.